NCT03830151View on ClinicalTrials.gov

Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 16, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Primary Brain Neoplasm
Interventions
DRUG

Hyperpolarized Carbon C 13 Pyruvate

Given IV

PROCEDURE

Magnetic Resonance Spectroscopic Imaging

Undergo MRSI

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER